Yulia Grishchuk Selected Research

glycylphenylalanine

1/2018

Robust lysosomal calcium signaling through channel TRPML1 is impaired by lysosomal lipid accumulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yulia Grishchuk Research Topics

Disease

8	Mucolipidoses (Sialidosis) 01/2022 - 12/2015
2	Iron Deficiencies 01/2020 - 12/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Rupture 01/2018
1	Retinal Dystrophies 01/2018
1	Disease Progression 09/2017
1	Atrophy 01/2016
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 12/2015
1	Hypoxia (Hypoxemia) 05/2014
1	Alzheimer Disease (Alzheimer's Disease) 05/2009
1	Myeloid Leukemia (Leukemia, Myelocytic) 05/2009
1	Ischemia 05/2009

Drug/Important Bio-Agent (IBA)

3	IronIBA 10/2021 - 12/2015
3	Transient Receptor Potential ChannelsIBA 01/2021 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 05/2009
1	CytokinesIBA 01/2022
1	Ferritins (Ferritin)IBA 01/2020
1	glycylphenylalanineIBA 01/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	CalciumIBA 01/2018
1	Phosphates (Orthophosphate)IBA 01/2018
1	ThapsigarginIBA 01/2018
1	miglustat (Zavesca)FDA Link 09/2017
1	Retinaldehyde (Retinal)IBA 01/2016
1	Ion Channels (Ion Channel)IBA 12/2015
1	Oxygen (Dioxygen)IBA 05/2014
1	Kainic Acid (Kainate)IBA 05/2014
1	epsinIBA 05/2009
1	Vesicular Transport Adaptor ProteinsIBA 05/2009
1	ClathrinIBA 05/2009

Therapy/Procedure

1	Therapeutics 01/2016